authentica solutions | $6,200,000 | (Jun 28, 2024)
Pear Commerce | $10,000,000 | (Jun 28, 2024)
Synthpop - Healthcare AI | $5,600,000 | (Jun 28, 2024)
HeartFlow, Inc
United States
- Mountain View, California
- 07/04/2023
- Series F
- $215,000,000
HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide.
Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlow’s footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics.
We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care.
For more information, visit www.heartflow.com.
- Industry Medical Equipment Manufacturing
- Website https://www.heartflow.com/
- LinkedIn https://www.linkedin.com/company/heartflow-inc/
Related People
John FarquharFounder
United States -
San Francisco Bay Area
Experienced healthcare executive focused on building high performing teams and businesses. Interested in helping innovative healthcare companies grow and patients gain access to better therapies and outcomes.
Proven global experience in P&L management, sales and marketing leadership, new product launches, turnarounds and market development across multiple geographies (Asia Pacific and Americas) and segments (Cardiovascular, Diabetes and Consumer Health.)
Specialties: General Management, P&L Management, Strategy, Business Development, Sales Leadership, Marketing, New Product Development, New Product Launches, SAAS, AI, Machine Learning, Operations, Market Development, Market Access, Asia Pacific, Medical Devices, Diabetes, Cardiology and Vascular Surgery
Supercede | The Reinsurance Platform | $15,000,000 | (Jun 28, 2024)
illumex | $13,000,000 | (Jun 28, 2024)
AuthZed | $12,000,000 | (Jun 28, 2024)
Smartworks | $12,000,000 | (Jun 28, 2024)
Synthflow AI | $7,400,000 | (Jun 28, 2024)
Odaseva | $54,000,000 | (Jun 28, 2024)
Heidi | $7,075,684 | (Jun 28, 2024)
KarmaCheck | $45,000,000 | (Jun 28, 2024)
Dodona Analytics | Undisclosed Amount | (Jun 28, 2024)
Ginossar Ventures | $13,000,000 | (Jun 28, 2024)